Volume 20, Issue 9, September 2022
Meet the Country Editor
Pp: 1641-1641
Author: A. Fernández-Teruel
DOI: 10.2174/1570159X2009220616113313
Published on: 16 June, 2022
The Role of Epigenetics in the Pathogenesis and Potential Treatment of Attention Deficit Hyperactivity Disorder
Pp: 1642-1650
Author: Jacob Peedicayil*
DOI: 10.2174/1570159X19666210920091036
Published on: 30 March, 2022
The Potential Role of Hypoxia-Inducible Factor-1 in the Progression and Therapy of Central Nervous System Diseases
Pp: 1651-1666
Author: Hongxiu Chen, Di Ma, Feixue Yue, Yajie Qi, Manman Dou, Liuping Cui and Yingqi Xing*
DOI: 10.2174/1570159X19666210729123137
Published on: 30 March, 2022
A Review on Preclinical Models of Ischemic Stroke: Insights Into the Pathomechanisms and New Treatment Strategies
Pp: 1667-1686
Author: Aditya A. Singh, Akash Kharwar and Manoj P. Dandekar *
DOI: 10.2174/1570159X19666210907092928
Published on: 30 March, 2022
High-Frequency Oscillations and Epileptogenic Network
Pp: 1687-1703
Author: Xiaonan Li, Herui Zhang, Huanling Lai, Jiaoyang Wang, Wei Wang and Xiaofeng Yang*
DOI: 10.2174/1570159X19666210908165641
Published on: 20 April, 2022
GABAB Receptors: are they Missing in Action in Focal Epilepsy Research?
Pp: 1704-1716
Author: Massimo Avoli* and Maxime Lévesque
DOI: 10.2174/1570159X19666210823102332
Published on: 30 March, 2022
Neuroprotective Effects of Neuropeptide Y against Neurodegenerative Disease
Pp: 1717-1725
Author: Stéphanie Pain, Sébastien Brot and Afsaneh Gaillard*
DOI: 10.2174/1570159X19666210906120302
Published on: 24 March, 2022
Homocysteinylation and Sulfhydration in Diseases
Pp: 1726-1735
Author: Si-Min Chen and Xiao-Qing Tang*
DOI: 10.2174/1570159X20666211223125448
Published on: 28 March, 2022
Herb-drug Interactions in Neuropsychiatric Pharmacotherapy – A Review of Clinically Relevant Findings
Pp: 1736-1751
Author: Tram T. Le, Sarah R. McGrath and Pius S. Fasinu*
DOI: 10.2174/1570159X19666210809100357
Published on: 30 March, 2022
Traumatic Internal Carotid Artery Injuries: Do We Need a Screening Strategy? Literature Review, Case Report, and Forensic Evaluation
Pp: 1752-1773
Author: Aniello Maiese, Paola Frati, Alice Chiara Manetti, Alessandra De Matteis, Marco Di Paolo, Raffaele La Russa, Emanuela Turillazzi, Alessandro Frati and Vittorio Fineschi*
DOI: 10.2174/1570159X19666210712125929
Published on: 30 March, 2022
Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study
Pp: 1774-1782
Author: Haixia Liu, Rui Yu, Yanan Gao, Xirong Li, Xiaoni Guan, Kosten Thomas, Meihong Xiu* and Xiangyang Zhang*
DOI: 10.2174/1570159X19666210920090547
Published on: 30 March, 2022
Ameliorating Alzheimer’s-like Pathology by Minocycline via Inhibiting Cdk5/p25 Signaling
Pp: 1783-1792
Author: Yu Zhao*, Chuanling Wang, Wenbo He and Zhiyou Cai*
DOI: 10.2174/1570159X19666211202124925
Published on: 31 March, 2022
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study
Pp: 1793-1803
Author: Haixia Liu, Hua Liu, Shuling Jiang, Lei Su, Yi Lu, Zhenli Chen, Xiaojing Li, Xirong Li, Xuemei Wang*, Meihong Xiu* and Xiangyang Zhang*
DOI: 10.2174/1570159X19666211111123918
Published on: 21 April, 2022
